These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 28573622

  • 1. Assessment of Inhibition of Ebola Virus Progeny Production by Antiviral Compounds.
    Falzarano D.
    Methods Mol Biol; 2017; 1628():203-210. PubMed ID: 28573622
    [Abstract] [Full Text] [Related]

  • 2. High-throughput drug screening using the Ebola virus transcription- and replication-competent virus-like particle system.
    Lee N, Shum D, König A, Kim H, Heo J, Min S, Lee J, Ko Y, Choi I, Lee H, Radu C, Hoenen T, Min JY, Windisch MP.
    Antiviral Res; 2018 Oct; 158():226-237. PubMed ID: 30149038
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Inhibition of Ebola and Marburg Virus Entry by G Protein-Coupled Receptor Antagonists.
    Cheng H, Lear-Rooney CM, Johansen L, Varhegyi E, Chen ZW, Olinger GG, Rong L.
    J Virol; 2015 Oct; 89(19):9932-8. PubMed ID: 26202243
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. An RNA polymerase II-driven Ebola virus minigenome system as an advanced tool for antiviral drug screening.
    Nelson EV, Pacheco JR, Hume AJ, Cressey TN, Deflubé LR, Ruedas JB, Connor JH, Ebihara H, Mühlberger E.
    Antiviral Res; 2017 Oct; 146():21-27. PubMed ID: 28807685
    [Abstract] [Full Text] [Related]

  • 8. Assessing Antiviral Countermeasures Using Mouse Models of Ebolavirus Infection.
    Kroeker A, Griffin BD, Qiu X, Kobinger G.
    Methods Mol Biol; 2017 Oct; 1628():273-282. PubMed ID: 28573628
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A high throughput screen identifies benzoquinoline compounds as inhibitors of Ebola virus replication.
    Luthra P, Liang J, Pietzsch CA, Khadka S, Edwards MR, Wei S, De S, Posner B, Bukreyev A, Ready JM, Basler CF.
    Antiviral Res; 2018 Feb; 150():193-201. PubMed ID: 29294299
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Enhancing the antiviral potency of ER α-glucosidase inhibitor IHVR-19029 against hemorrhagic fever viruses in vitro and in vivo.
    Ma J, Zhang X, Soloveva V, Warren T, Guo F, Wu S, Lu H, Guo J, Su Q, Shen H, Solon E, Comunale MA, Mehta A, Guo JT, Bavari S, Du Y, Block TM, Chang J.
    Antiviral Res; 2018 Feb; 150():112-122. PubMed ID: 29253498
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Small molecule inhibitors of ebola virus infection.
    Picazo E, Giordanetto F.
    Drug Discov Today; 2015 Feb; 20(2):277-86. PubMed ID: 25532798
    [Abstract] [Full Text] [Related]

  • 17. Modeling the Ebolavirus Life Cycle with Transcription and Replication-Competent Viruslike Particle Assays.
    Biedenkopf N, Hoenen T.
    Methods Mol Biol; 2017 Feb; 1628():119-131. PubMed ID: 28573615
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Addressing Therapeutic Options for Ebola Virus Infection in Current and Future Outbreaks.
    Haque A, Hober D, Blondiaux J.
    Antimicrob Agents Chemother; 2015 Oct; 59(10):5892-902. PubMed ID: 26248374
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.